Hematopoietic stem cell transplantation.

M. S. Wright-Kanuth, L. A. Smith

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Hematopoietic stem cells have been shown to provide the best chance for long term patient engraftment in bone marrow transplantation, peripheral blood stem cell transplantation, and umbilical cord blood transplantation. Characteristics of these cells include the ability to divide without differentiating; presence in bone marrow, peripheral blood, and cord blood; and negativity for all lineage CD markers. Autologous, syngeneic, and allogeneic transplantations have all been performed and patients respond well. Complications include graft rejection or failure and graft-versus-host disease; however, such complications can be minimized and treated. Hematopoietic stem cell transplantation holds promise for the treatment of many malignancies and metabolic diseases that have not responded to other forms of treatment.

Original languageEnglish (US)
Pages (from-to)112-117
Number of pages6
JournalClinical laboratory science : journal of the American Society for Medical Technology
Volume14
Issue number2
StatePublished - Mar 2001
Externally publishedYes

Fingerprint

Hematopoietic Stem Cell Transplantation
Stem cells
Fetal Blood
Blood
Isogeneic Transplantation
Peripheral Blood Stem Cell Transplantation
Autologous Transplantation
Metabolic Diseases
Homologous Transplantation
Graft Rejection
Graft vs Host Disease
Hematopoietic Stem Cells
Bone Marrow Transplantation
Grafts
Bone
Transplantation
Bone Marrow
Therapeutics
Neoplasms

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Hematopoietic stem cell transplantation. / Wright-Kanuth, M. S.; Smith, L. A.

In: Clinical laboratory science : journal of the American Society for Medical Technology, Vol. 14, No. 2, 03.2001, p. 112-117.

Research output: Contribution to journalArticle

@article{bdaa38823111488ea13d2c6c0fa58eba,
title = "Hematopoietic stem cell transplantation.",
abstract = "Hematopoietic stem cells have been shown to provide the best chance for long term patient engraftment in bone marrow transplantation, peripheral blood stem cell transplantation, and umbilical cord blood transplantation. Characteristics of these cells include the ability to divide without differentiating; presence in bone marrow, peripheral blood, and cord blood; and negativity for all lineage CD markers. Autologous, syngeneic, and allogeneic transplantations have all been performed and patients respond well. Complications include graft rejection or failure and graft-versus-host disease; however, such complications can be minimized and treated. Hematopoietic stem cell transplantation holds promise for the treatment of many malignancies and metabolic diseases that have not responded to other forms of treatment.",
author = "Wright-Kanuth, {M. S.} and Smith, {L. A.}",
year = "2001",
month = "3",
language = "English (US)",
volume = "14",
pages = "112--117",
journal = "Journal of Medical Technology",
issn = "0894-959X",
publisher = "American Society for Clinical Laboratory Science",
number = "2",

}

TY - JOUR

T1 - Hematopoietic stem cell transplantation.

AU - Wright-Kanuth, M. S.

AU - Smith, L. A.

PY - 2001/3

Y1 - 2001/3

N2 - Hematopoietic stem cells have been shown to provide the best chance for long term patient engraftment in bone marrow transplantation, peripheral blood stem cell transplantation, and umbilical cord blood transplantation. Characteristics of these cells include the ability to divide without differentiating; presence in bone marrow, peripheral blood, and cord blood; and negativity for all lineage CD markers. Autologous, syngeneic, and allogeneic transplantations have all been performed and patients respond well. Complications include graft rejection or failure and graft-versus-host disease; however, such complications can be minimized and treated. Hematopoietic stem cell transplantation holds promise for the treatment of many malignancies and metabolic diseases that have not responded to other forms of treatment.

AB - Hematopoietic stem cells have been shown to provide the best chance for long term patient engraftment in bone marrow transplantation, peripheral blood stem cell transplantation, and umbilical cord blood transplantation. Characteristics of these cells include the ability to divide without differentiating; presence in bone marrow, peripheral blood, and cord blood; and negativity for all lineage CD markers. Autologous, syngeneic, and allogeneic transplantations have all been performed and patients respond well. Complications include graft rejection or failure and graft-versus-host disease; however, such complications can be minimized and treated. Hematopoietic stem cell transplantation holds promise for the treatment of many malignancies and metabolic diseases that have not responded to other forms of treatment.

UR - http://www.scopus.com/inward/record.url?scp=16644389756&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=16644389756&partnerID=8YFLogxK

M3 - Article

C2 - 15625984

AN - SCOPUS:16644389756

VL - 14

SP - 112

EP - 117

JO - Journal of Medical Technology

JF - Journal of Medical Technology

SN - 0894-959X

IS - 2

ER -